"A little more than a century ago a diagnosis of type 1 diabetes was a death sentence. Today, thanks to extraordinary scientific progress, many people with type 1 diabetesespecially in developed countriescan enjoy long, healthy lives. I'm profoundly grateful that my older son, now 16, was born into this era of possibility. His diagnosis in 2020 came at a time when innovation and advocacy had transformed what it meant to live with this chronic autoimmune disease."
"Yet the pursuit of a true cure continues. Health journalist Tara Haelle delves into promising options, including beta cell transplants that would eliminate the need for immunosuppressive drugs. She also highlights the monoclonal antibody teplizumab, approved in 2022, which can delay the onset of symptomatic type 1 diabetes by five years or more in some peoplea milestone in preventive medicine."
A century ago a diagnosis of type 1 diabetes was effectively a death sentence; today many people, especially in developed countries, can live long, healthy lives due to scientific progress. Closed-loop artificial pancreas systems integrate insulin pumps and continuous glucose monitors to mimic healthy beta cell function and simplify daily management. Research into beta cell transplants seeks to remove the need for lifelong immunosuppression. The monoclonal antibody teplizumab, approved in 2022, can delay onset of symptomatic type 1 diabetes by around five years or more for some individuals. Incidence of type 1 diabetes is increasing even as prevention and treatment options expand.
Read at www.scientificamerican.com
Unable to calculate read time
Collection
[
|
...
]